Volcano Therapeutics fractional flow reserve FFR guidewires

Register to receive a free U.S. Market for Interventional Cardiology Devices report synopsis and brochure

New technologies like fractional flow reserve (FFR) guidewires within the diagnostic coronary catheters and guidewires market is one the fastest growing segments within the interventional cardiology market. Despite the adoption of alternative screening methods, and limited unit sales due to a recent decrease in angioplasties and the number of catheters used per procedure, the rapidly growing adoption of FFR guidewires has alleviated sales pressure significantly.

“The FFR guidewire market will continue to grow due to positive clinical results from increased ease-of-use thanks to FFR console integration into cath labs,” explains Dr. Kamran Zamanian, CEO of iData. “Additionally, FFR guided percutaneous coronary intervention procedures cost less than standard procedures without prolonging procedure times.”

As procedure numbers increase over time, so will the sales of diagnostic catheters. However, unit growth will be lower in comparison to the rise in rate of procedures. The reason for this difference is that the progression of transthoracic technology has been applied to diagnostic procedures, allowing the left ventricle to be accessed without a catheter. Therefore, despite an increase in procedures being performed, fewer catheters are being used per procedure.

Other key findings from the 2015 iData Research report series entitled U.S. Market for Interventional Cardiology Devices:

Future Procedure Numbers
High rates of obesity, diabetes and the increasing age of the U.S population are driving the demand for diagnostic procedures. The U.S. population is also becoming much more aware of the dangers of cardiovascular disease. This is also increasing the overall number of screening procedures in the country.

Leading Competitors
Volcano Therapeutics is the leading competitor in the FFR guidewire market where they have over half the market share. Because of the high value of the FFR guidewire market, Volcano’s strong market share in this rapidly growing segment translated into nearly 30% of the overall diagnostic coronary catheters and guidewires market. Volcano has gained market share in the FFR guidewire market because of the integration of their FFR devices into their newest intravascular ultrasound consoles. As demand for combination devices increases, Volcano will be well placed to capitalize on the opportunity and increase their share in the market.

Other notable competitors in the diagnostic coronary catheter and guidewire market include St. Jude Medical, Cordis, Boston Scientific, Medtronic, Cook Medical, Merit Medical Systems, C.R. Bard, Abbott Laboratories, AngioDynamics, St. Jude Medical, Terumo, and Teleflex Medical among others.

For Further Information
More on the diagnostic coronary catheter and guidewire market in the U.S. can be found in the report published by iData entitled U.S. Market for Interventional Cardiology Devices. This report also covers the U.S. market segments for bare-metal and drug-eluting stents, PTCA and cutting balloons, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices, coronary atherectomy devices, coronary thrombectomy devices, coronary chronic total occlusion crossers, introducer sheaths, coronary vascular closure devices, diagnostic coronary catheter and guidewires, intravascular ultrasound catheters, and optical coherence tomography catheters.

The iData series on the market for interventional cardiology devices covers the U.S., Japan, Brazil, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

To find out more about U.S interventional cardiology market data or procedure data, register online or email us at [email protected] for a U.S. Market for Interventional Cardiology Devices report brochure and synopsis.

About Procedure Tracker
Additional procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch